Key facts
- This page summarizes Michael Crowley's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2025, 16:36.
Michael Crowley - 14 Mar 2025 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)
- Reporting relationship
- EVP, GBL Commercial Operations
- Issuer ticker
- BIO
- Reported as of
- 14 Mar 2025
- Net transaction value
- -$263,224
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2025, 16:36:38 UTC
- Prior SEC filing
- 10 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Crowley
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Michael Crowley filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 18 Mar 2025.
Change
- Previous filing in this sequence was filed on 10 Sep 2024.
- Current net transaction value: -$263,224.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO BIO.B
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- $477,960
- Shares
- +3,000
- Change %
- +37%
- Price
- $159.32
- Shares after
- 11,171
- Date
- 14 Mar 2025
- Ownership
- Direct
BIO BIO.B
transaction
Bio-Rad A Common Stock
Sale
- Transaction value
- $741,184
- Shares
- -3,000
- Change %
- -27%
- Price
- $247.06
- Shares after
- 8,171
- Date
- 14 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO BIO.B
transaction
Derivative
Non-Qualified Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 14 Mar 2025
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 3,000
- Exercise price
- $159.32
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F2
The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.